| Literature DB >> 33034443 |
Sara M Imani1, Liane Ladouceur1, Terrel Marshall2, Roderick Maclachlan2, Leyla Soleymani1,2, Tohid F Didar1,3,4.
Abstract
The global COVID-19 pandemic has attracted considerable attention toward innovative methods and technologies for suppressing the spread of viruses. Transmission via contaminated surfaces has been recognized as an important route for spreading SARS-CoV-2. Although significant efforts have been made to develop antibacterial surface coatings, the literature remains scarce for a systematic study on broad-range antiviral coatings. Here, we aim to provide a comprehensive overview of the antiviral materials and coatings that could be implemented for suppressing the spread of SARS-CoV-2 via contaminated surfaces. We discuss the mechanism of operation and effectivity of several types of inorganic and organic materials, in the bulk and nanomaterial form, and assess the possibility of implementing these as antiviral coatings. Toxicity and environmental concerns are also discussed for the presented approaches. Finally, we present future perspectives with regards to emerging antimicrobial technologies such as omniphobic surfaces and assess their potential in suppressing surface-mediated virus transfer. Although some of these emerging technologies have not yet been tested directly as antiviral coatings, they hold great potential for designing the next generation of antiviral surfaces.Entities:
Keywords: COVID-19; antimicrobial coatings; antiviral surfaces; engineered surfaces; nanocoatings; pathogen-repellent surfaces; photoactive materials; virus inactivation; virus repellent
Mesh:
Substances:
Year: 2020 PMID: 33034443 PMCID: PMC7553040 DOI: 10.1021/acsnano.0c05937
Source DB: PubMed Journal: ACS Nano ISSN: 1936-0851 Impact factor: 15.881
Figure 1Schematic diagram of the current research and emerging antiviral coatings and surfaces, including metal and inorganic nanomaterials, polymeric and organic coatings, and emerging technologies such as omniphobic pathogen-repellent coatings.
Figure 2Antiviral mechanisms of inorganic materials. (a) Antimicrobial contact killing mechanisms for copper include membrane degradation, genotoxicity, and potentially ROS. Reprinted with permission from ref (12). Copyright 2018 John Wiley and Sons. (b) Four prominent routes of antimicrobial action for silver include adhesions to cell membrane (i), penetration into cell and nucleus (ii), cellular toxicity and ROS generation (iii), and modulation of cell signaling (iv). Reprinted with permission from ref (32). Copyright 2016 Dakal, Kumar, Majumdar, and Yadav. (c) Actions of zinc throughout the cell and proposed mechanisms for antiviral properties include free virus inactivation (1), inhibition of viral uncoating (2), viral genome transcription (3), and viral protein translation and polyprotein processing (4) Reprinted with permission from ref (33). Copyright 2019 Oxford University Press. (d) Photocatalytic process by which TiO2 nanoparticles and TiO2 compounds produce reactive oxygen species to cause disturbance of lipid membranes and damage to genetic information, ultimately resulting in bacterial cell death or viral inactivation. Reprinted with permission from ref (34). Copyright 2017 Elsevier.
Metal and Inorganic Antiviral Materials
| virus | |||||||
|---|---|---|---|---|---|---|---|
| material form | name | envelope | genetic material | virucidal activity | deactivation time | proposed applications | ref |
| Copper | |||||||
| solid state | influenza A | enveloped | negative-sense ssRNA | 2 × 106 reduced to 500 infectious virus particles | 6 h | replacement of steel fittings; copper surfaces in schools and healthcare facilities | ( |
| solid (coupons) | bacteriophage Φ6 | enveloped | dsRNA | 2-log decline | 1 h | noted copper usage in sanitary and medical contexts | ( |
| solid state (coupons) | monkeypox | enveloped | dsDNA | complete viral inactivation uponcontact | 3 min | positioned as useful in hospital trials | ( |
| vaccinia virus | enveloped | dsDNA | complete viral inactivation upon of contact | 3 min | |||
| copper alloys | murine norovirus | non-enveloped | positive-sense ssRNA | suggest use of copper alloys as dry surfaces in health care and community environments to prevent spread of pathogens, in combination with regular and efficient cleaning and decontamination regimes | ( | ||
| copper/zinc alloy | human coronavirus 229E | enveloped | positive-sense ssRNA | inactivation for dry fingertip method 103 PFU in wet-droplet contamination (20 μL per cm2) inactivated | incorporation of copper alloy surfaces along with effective cleaning regimens and good clinical practice | ( | |
| solid-state oxide (cuprous oxide) | influenza A | enveloped | negative-sense RNA | 3.7-log reduction after exposure to 2.1 μmol on glass slide | 30 min | tackle novel forms of the virus and potential resistance to drugs to reduce transmission; treatment of both public and living spaces to help limit or prevent future pandemics | ( |
| solid-state oxide (cuprous oxide) | bacteriophage Qβ | non-enveloped | positive-sense ssRNA | 6-log reduction | 30 min | demonstrated potential for public and private living environments to reduce the risk of infections from pathogens | ( |
| copper oxide within filters | rhinovirus-2 | non-enveloped | positive-sense ssRNA | 2 ± 1.7-log reduction | 2 min | represent an inexpensive way to quickly deactivate viruses in contaminated liquids | ( |
| yellow fever virus | enveloped | positive-sense ssRNA | 1.1 ± 0.5-log reduction | 2 min | |||
| influenza A | enveloped | negative-sense RNA | 1.77 ± 0.87-log reduction | 2 min | |||
| measles virus | enveloped | negative-sense ssRNA | ≥3.67-log reduction | 2 min | |||
| respiratory syncytial | enveloped | negative-sense ssRNA | 1.5 ± 0.5-log reduction | 2 min | |||
| parainfluenza virus 3 | enveloped | negative-sense ssRNA | 1.11 ± 0.5-log reduction | 2 min | |||
| Punta Toro virus | enveloped | negative-sense ssRNA | 1.73 ± 1.55-log reduction | 2 min | |||
| Pichinde virus | enveloped | negative-sense ssRNA | 1.7 ± 1.47-log reduction | 2 min | |||
| HIV-1 | enveloped | positive-sense ssRNA | 4.6 ± 0.6-log reduction | 2 min | |||
| adenovirus | non-enveloped | dsDNA | 2.2 ± 0.36-log reduction | 2 min | |||
| cytomegalovirus | enveloped | dsDNA | 4.3 ± 0.26-log reduction | 2 min | |||
| vaccinia virus | enveloped | dsDNA | 0.47 ± 0.45-log reduction | 2 min | |||
| copper oxide impregnated face masks | influenza A | enveloped | negative-sense RNA | no infectious titers recovered from surface | 30 min | reduction of contamination risk during use or removal of masks | ( |
| ionic impregnation of latex and filters | HIV-1 | enveloped | positive-sense ssRNA | example of reduction of
nosocomial infections in hospitals using copper in
fabrics, paper, latex,
| ( | ||
| West Nile virus | enveloped | positive-sense ssRNA | 5-log reduction | 5 mL/min | |||
| zeolite textiles, Cu2+ | H5N1 avian influenza | enveloped | negative-sense ssRNA | CuZeo textile has wide
applications as a microbicidal agent or in
environmental healthcare goods; can be applied as
a comprehensive healthcare item such as in
protective wear (clothes, masks, and gloves),
sheets covering beds or pillows in hospitals, and
air or water purifiers in facilities such as
hospitals or farms, | ( | ||
| H5N3 avian influenza | enveloped | negative-sense ssRNA | >5.0-log reduction for Whi.s/Shimane/499/83 | 10 min | |||
| nanoparticles within coating | influenza H1N1 | enveloped | negative-sense ssRNA | complete inactivation | 1 min | authors propose that this antipathogen coating can provide an additional measure of protection against the spread of diseases in natural and manmade disasters and during outbreaks of disease in either human or animal populations | ( |
| copper powder within spray | influenza A | enveloped | negative-sense RNA | 100% inhibition | 10 min | demonstration of spray coating that is effective as an antimicrobial, which can be used on surfaces within healthcare facilities | ( |
| Silver | |||||||
| hybrid coating (ionic) | HIV-1 | enveloped | positive-sense ssRNA | 99.8% reduction | 20 min | broad-spectrum antimicrobial surface coating would have great impact on the battle against hospital-acquired infections; potential to provide antimicrobial protection on surfaces and materials in hospital settings | ( |
| dengue virus | enveloped | positive-sense ssRNA | 1.1-log TCID50 reduction | 4 h | |||
| HSV | enveloped | dsDNA | complete inactivation | 4 h | |||
| influenza | enveloped | negative-sense ssRNA | 0.7-log TCID50 reduction | 4 h | |||
| coxsackie | non-enveloped | positive-sense ssRNA | 0.2-log TCID50 reduction | 4 h | |||
| silver nitrate in solution | feline calicivirus | non-enveloped | positive-sense ssRNA | 3-log reduction in recovery in 2.1 mg/L concentration | 75 days | technology proposed here would allow for custom design of active, adaptive packaging and contact surfaces | ( |
| murine norovirus | non-enveloped | positive-sense ssRNA | 1-log reduction after 75 days with 2.1 mg/L concentration | 75 days | |||
| nanoparticle in solution or film | feline calicivirus | non-enveloped | positive-sense ssRNA | ||||
| murine norovirus | non-enveloped | positive-sense ssRNA | |||||
| nanoparticle impregnation of nanofiber sheets | influenza A (A/PR/8/34 (H1N1)) | enveloped | negative-sense RNA | 2-log decrease at concentration of AgNPs at 8.5 μL/cm2 | 1 h | chitin–nanofiber sheets with potential to act as wound dressings | ( |
| nanoparticle within graphene oxide | infectious bursa virus | non-enveloped | dsRNA | 0.125 mg/mL led to complete inhibition of 9 × 102 TCID50/mL | 1 h | further application of GO and GO-Ag can be considered for personal protection equipment to decrease the transmission of viruses | ( |
| 1 mg/mL against the infection of 9 × 103 TCID50/mL | |||||||
| feline coronavirus | enveloped | positive-sense, ssRNA | 0.1 mg/mL caused 24.8% inhibition for 4.7 × 104 TCID50/mL | 1 h | |||
| nanoparticle within membrane | bacteriophage MS2 | non-enveloped | positive-sense ssRNA | (5 ± 0.2) × 105 PFU/mL completely removed | flow rate not reported | membranes used for water treatment | ( |
| nanoparticle within membrane | bacteriophage UZ1 | 3.4-log decrease in virus load | flux of 3.1 L m–2 h–1 | development of an innovative strategy for preventing outbreaks of waterborne diseases | ( | ||
| nanoparticle within film | feline calicivirus | non-enveloped | positive-sense ssRNA | >4.4-log TCID50/mL reduction after contact with films | 24 h | excellent potential for PLA–silver films for food contact applications as well as in active packaging technologies for food safety and quality | ( |
| nanoparticle within filter | bacteriophage MS2 virus | non-enveloped | positive-sense ssRNA | density of 1.5 × 109 particles/cm2 demonstrates roughly 70% antiviral efficiency without the presence of dust | 15 min | use as air filters within all types of public facilities | ( |
| Zinc | |||||||
| solid state | murine norovirus | non-enveloped | ssRNA | 1-log reduction for pure zinc | 2 h | Suggests the incorporation of copper alloy surfaces to help prevent infection spread, such as within hospitals | ( |
| zinc oxide filopodia-like structures | herpes simplex virus type 1 | enveloped | dsDNA | dose-dependent reduction of viral entry; incubation with 100 μg/mL ZnO-MNSs led to below 20% entry | 90 min | suggests development of these micro-nanostructures as a topical agent for prevention of HSV-1 infection | ( |
| ionic solution | human rhinovirus | non-enveloped | positive-sense ssRNA | 99% reduction in number plaques using zinc chloride after virus exposure | 1 h | investigation focused on the mechanism of action | ( |
| TiO2 | |||||||
| colloidal nanoparticles | Newcastle disease virus | enveloped | negative-sense ssRNA | qualitative; chick allantoises did not hemagglutinate after incubation with nanocolloids | 96 h | starting point for the development of antiviral drugs | ( |
| solid-state coating | influenza virus | enveloped | negative-sense ssRNA | 3.6-log reduction (UVA intensity 0.1 mW/cm2) | 4 h | integration into surfaces in high-risk environments to reduce the spread of infection, such as at hospitals and daycare centers | ( |
| feline calicivirus | non-enveloped | positive-sense ssRNA | 1.7-log reduction (UVA intensity 0.1 mW/cm2) | 8 h | |||
| solid-state anatase coating | bacteriophage Qβ | non-enveloped | positive-sense ssRNA | 4.5-log reduction (UVA intensity 0.1 mW/cm2) | 4 h | prevention of viral transmission in indoor and outdoor living spaces | ( |
| bacteriophage T4 | non-enveloped | dsDNA | 2-log reduction (UVA intensity 0.1 mW/cm2) | 4 h | |||
| fluorinated nanoparticles | bacteriophage MS2 | non-enveloped | positive-sense ssRNA | 2.6-log reduction (UVA intensity 0.01 mW/cm2) | 60 min | prevention of viral transmission in indoor commercial spaces with fluorescent lighting | ( |
| feline calicivirus | non-enveloped | positive-sense ssRNA | 2.0-log reduction (UVA intensity 0.01 mW/cm2) | 60 min | |||
| murine norovirus | non-enveloped | positive-sense ssRNA | 2.6-log reduction (UVA intensity 0.01 mW/cm2) | 6 min | |||
| Ag- and Cu-doped nanowire membranes | bacteriophage MS2 | non-enveloped | positive-sense ssRNA | 4.02-log reduction after filtration | 30 min | filtration and disinfection of drinking water | ( |
| Ag-doped solid-state coating | influenza A | enveloped | negative-sense ssRNA | ≥4.17-log reduction (15 W UVA light from 35 cm) | 20 min | disinfection of publicly used surfaces and breakdown of organic pollutants | ( |
| enterovirus | non-enveloped | positive-sense ssRNA | ≥4.17-log reduction (15 W UVA light from 35 cm) | 20 min | |||
| Other inorganic antiviral materials | |||||||
| modified gold nanoparticle in solution | virus-like particles (VLPs), replicating human norovirus, GI.1 VLPs | replicates non-enveloped | replicates RNA | complete inactivation of VLPs at a concentration of 0.37 μg/mL using 0.083 μM Au/CuS NPs | 1 h | proposed as an antiviral | ( |
| multivalent gold nanoparticles with sulfate ligands | HIV | enveloped | positive-sense ssRNA | <20% infection rate of T-cells after incubation with sulfonated gold nanoparticles | 30 min | development of a multifunctional therapeutic anti-HIV system | ( |
| gold nanoparticles with undecanesulfonic acid-containing ligands | HSV-1 | enveloped | dsDNA | irreversible loss of infectivity (0 PFU) after preincubation of virus with gold NPs | 1 h | production of virucidal drugs to fight viral infections | ( |
| HSV-2 | enveloped | dsDNA | irreversible loss of infectivity (0 PFU) after preincubation of virus with gold NPs | 1 h | |||
| human papillomavirus type 16 | non-enveloped | dsDNA | irreversible loss of infectivity (0 FFU) after preincubation of virus with gold NPs | 1 h | |||
| RSV | enveloped | negative-sense ssRNA | irreversible loss of infectivity (0 PFU) after preincubation of virus with gold NPs | 1 h | |||
| vesicular stomatitis virus pseudotyped lentivirus (LV-VSV-G) | enveloped | negative-sense ssRNA | irreversible loss of infectivity (0 transduction units) after preincubation of virus with gold NPs | 1 h | |||
| adenovirus-5 | non-enveloped | dsDNA | no inhibition (virus is not HSPG-dependent) | 1 h | |||
| ion doping of coating with transition
metals ( | influenza H1N1 | enveloped | negative-sense RNA | 99% eradication with a fluorescent lamp | 30 min | suggests use for inactivation of virus inside buildings with fluorescent light | ( |
| silica nanoparticle in coating | influenza A/PR/8/34 (H1N1) | enveloped | negative-sense RNA | complete inactivation after incubation of virus suspension on surface | 30 min | use as a microbicidal coating | ( |
| nonstoichiometric perovskite-type
La | influenza A | enveloped | negative-sense RNA | neutralized 76% of influenza A | 15 min | proposed as a sterilizing method to
minimize transmission of virus
| ( |
Figure 3Examples of inorganic antiviral coatings. (a) Copper impregnation on a face mask. Reprinted with permission from ref (28). Copyright 2010 Borkow et al. (b) Demonstration of virucidal capabilities conferred through a multifunctional antimicrobial and antiviral coating consisting of micelles containing copper nanoparticles. (i) TEM image of influenza H1N1; (ii) TEM image of H1N1 virus after contact with coating. Reprinted with permission from ref (31). Copyright 2018 Royal Society of Chemistry. (c) (i) Surface of composite nanostructured anatase–rutile-carbon (NsARC) coating on stainless steel. (ii) SEM of NsARC coating surface morphology. (iii) SEM of NsARC coating cross section. The nanoscale features resembling anatase sheets (mille feuille) and rutile cones (strobili) increase the coating’s surface area, promoting efficient charge separation to elicit the photocatalytic effect. (iv) Reduction in the number of E. coli live cells after 4 h exposure to UV light, visible light, and dark conditions on uncoated stainless steel and NsARC-coated stainless steel. Reprinted from ref (51). Licensed under Creative Commons 2019. (d) Antiviral performance of a TiO2 solid coating on glass with UVA irradiation intensities of 0, 0.001, 0.01, and 0.1 mW/cm2 against (i) bacteriophage Qβ and (ii) bacteriophage T4. Reprinted with permission from ref (52). Copyright 2011 Royal Society of Chemistry.
Figure 4Polycation coatings. (a) Mechanism of enveloped virus inactivation by polycation coating. (i) diffusion of the virus particle to the surface from solution, (ii) adhesion on polycation surface, (iii) genomic material leaks out and the virus gets inactivated. Reprinted with permission from ref (79). Copyright 2011 National Academy of Sciences. (b) SEM images of influenza virus after exposure to uncoated (i) and N,N-dodecyl,methyl-PEI-coated (ii and iii) silicon wafers. Reprinted with permission from ref (79). Copyright 2011 National Academy of Sciences. (c) SEM images of a polyethylene surface coated with Quat-12-PU nanoparticles: (i) top view and (ii) cross section. Reprinted with permission from ref (88). Copyright 2013 Springer Nature. (d) SEM of Quat-12-PU electrospun nanofibers. Reprinted with permission from ref (88). Copyright 2013 Springer Nature. (e) Antiviral activities of uncoated and Quat-12-PU-coated polyethylene slides solution based or nanosuspension deposited. Reprinted with permission from ref (88). Copyright 2013 Springer Nature.
Polymeric and Organic Antiviral Coatings
| material | virus | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| coating | method | backbone material | name | envelope | genetic material | virucidal activity | deactivation time | proposed applications | ref |
| Polycations | |||||||||
| 4-bromobutyrylated
| covalent bonding | glass, glass powder | bacteriophages PRD1 | non-enveloped | dsDNA | 77 ± 3% titer reduction | 24 h | removing viruses from water by adsorption | ( |
| covalent bonding | glass | poliovirus | non-enveloped | positive-sense ssRNA | 100% virucidal activity (PFU/mL) | 30 min | disinfect aqueous solutions | ( | |
| physical absorption (painting) | polyethylene | poliovirus | non-enveloped | positive-sense ssRNA | ∼100% virucidal activity (PFU/mL) | 30 min | disinfect aqueous solutions | ( | |
| physical absorption (painting) | polyethylene | rotavirus | non-enveloped | dsRNA | 100% virucidal activity (PFU/mL) | 15 and 30 min | disinfect aqueous solutions | ( | |
| physical absorption (painting) | glass, polypropylene, polyethylene | WSN influenza strain WSN/33 (H1N1), PR/8/34 (H1N1), turkey/MN/833/80 (H4N2) | non-enveloped | negative-sense dsRNA | final viral titer (PFU/mL) = 0 | 5 min | not specified | ( | |
| 100% virucidal activity (PFU/mL) | antimicrobial surfaces | ||||||||
| viral nucleoprotein by ELISA = <0.1 PFU | |||||||||
| qRT-PCR RNA leakage detection <50% viral RNA in solution | |||||||||
| scanning electron microscopy survey for damaged viruses, 54% showed structural damage | |||||||||
| covalent aerosol-assisted plasma deposition | glass | influenza A/PR/8/34 (H1N1) | non-enveloped | negative-sense dsRNA | >4-log reduction in viral titer | 10 min | not specified | ( | |
| antimicrobial surfaces | |||||||||
| physical absorption (painting) | glass | influenza virus A/WSN/33 (H1N1) | enveloped | negative-sense ssRNA | 100% virucidal activity (PFU/mL) | 30 min | preventing the spread of infection | ( | |
| physical absorption (painting) | influenza A Wuhan (H3N2), avian influenza A turkey (H4N2) virus, drug-resistant strains of a human influenza A Wuhan (H3N2), and an avian influenza A turkey (H4N2) | enveloped | negative-sense ssRNA | final viral titer (PFU/mL) = 0 | 30 min | preventing the spread of influenza | ( | ||
| solution treated or nanoparticle treated by spray coating (physical absorption) | glass | influenza virus | enveloped | negative-sense ssRNA | final viral titer (PFU/mL) = 0 | 15 min | not specified | ( | |
| antimicrobial surfaces | |||||||||
| polyethyleneimine (25 kDa) | chemical cross-linking (covalent) | glass, microfiltration membranes | bacteriophage MS2 | non-enveloped | positive-sense ssRNA | 4-log of reduction in the virus titer | 30 min | filtration membranes for drinking water | ( |
| 3- to 3.5-log of reduction in the virus titer | |||||||||
| qRT-PCR for quantification of genome copies ∼2-log reduction | |||||||||
| polyethyleneimine (25 kDa) + AgNP and/or CuNP | chemical cross-linking (covalent) | glass, microfiltration membranes | bacteriophage MS2 | non-enveloped | positive-sense ssRNA | 4.5- to 5-log reduction in the virus titer | 30 min | filtration membranes for drinking water | ( |
| qRT- PCR for quantification of genome copies >2-log reduction | |||||||||
| quaternary ammonium compounds (QACs) | physical absorption by thin layer deposition | glass, plastic | influenza A (H1N1) | enveloped | negative-sense ssRNA | complete inactivation | 1 h | not specified | ( |
| poliovirus Sabin 1 | non-enveloped | positive-sense ssRNA | no inactivation observed | 1 h | antimicrobial surfaces | ||||
| Photosensitizer materials | |||||||||
| poly(vinyl
alcohol- | electrospinning followed by grafting | N/A (standalone membrane) | bacteriophage T7 | non-enveloped | dsDNA | 5-log PFU/mL reduction | 5 min daylight exposure | protection of high-risk surfaces and
personal protective equipment
( | ( |
| free-base
5-(4-aminophenyl)-10,15,20-tris(4- | covalent bonding | nanofibrillated cellulose | vesicular stomatitis virus (VSV) | enveloped | negative-sense ssRNA | final viral titer (PFU/mL) = 0 | 30 min illumination | integration in textiles for the prevention of nosocomial infections | ( |
| dengue-1 | enveloped | positive-sense ssRNA | final viral titer (PFU/mL) = 0 | 30 min illumination | |||||
| metalated
[5-(4-aminophenyl)-10,15,20-tris(4- | covalent bonding | nanofibrillated cellulose | vesicular stomatitis virus (VSV) | enveloped | negative-sense ssRNA | final viral titer (PFU/mL) = 0 | 30 min illumination | integration in textiles for the prevention of nosocomial infections | ( |
| dengue-1 | enveloped | positive-sense ssRNA | final viral titer (PFU/mL) = 0 | 30 min illumination | |||||
| cationic porphyrin | covalent bonding | cellulose fiber (paper) | dengue-1 | enveloped | positive-sense ssRNA | >99.995% reduction in FFU/mL | 30 min illumination | autonomously sterilize materials for hospitals and healthcare-related industries, preventing the spread of infection | ( |
| influenza A | enveloped | negative-sense ssRNA | ∼99.5% reduction in FFU/mL | 30 min illumination | |||||
| human adenovirus-5 (HAd-5) | non-enveloped | dsDNA | ∼99% reduction in FFU/mL | 30 min illumination | |||||
| rose bengal | covalent bonding | wipes with polypropylene fibers | murine norovirus 1 (MNV-1), | non-enveloped | positive-sense ssRNA | 8.7 h first 1-log reduction | 8.7 h | one-step procedure for cleaning and disinfecting influenza virus-contaminated surfaces | ( |
| human adenovirus type 5 (hAdV-5), | non-enveloped | dsDNA | 7 h first 1-log reduction | 7 h | |||||
| influenza virus H1N1 | enveloped | negative-sense ssRNA | immediate and complete inactivation (more than 4-log) | 0 min | |||||
| C60 | covalent bonding | SiO2 electrosprayed on a stainless-steel mesh | bacteriophage MS2 | non-enveloped | positive-sense ssRNA | inactivation levels at 5 cm distance = 55.8% | 3 h illumination | remote disinfection | ( |
| Other | |||||||||
| sodium pentaborate pentahydrate and triclosan | physical absorption by immersion | fabric | adenovirus type 5 | non-enveloped | dsDNA | 3-log decline in virus titer based on microscopic observation of the infected cells | not given | antiviral textile finishes for medical applications, daily use, and technical textiles | ( |
| poliovirus type 1 | non-enveloped | positive-sense ssRNA | 3-log decline in virus titer based on microscopic observation of the infected cells | not given | |||||
| poliovirus Sabin 1 | non-enveloped | positive-sense ssRNA | no inactivation observed | not applicable | |||||
Figure 5Photosensitizer–cellulose conjugate materials. (a) Schematic representation of the photosensitization process. Reprinted with permission from ref (93). Copyright 2012 Costa et al. (b) A3B3+-NFC and (c) Zn-A3B3+-NFC. Photodynamic inactivation studies of the (d) dengue-1 and (e) vesicular stomatitis virus. Dark yellow and dark green bars are dark controls. Light yellow and light green bars are illuminated. Black bar is the initial virus concentration. Slight decrease in the virus infectivity was observed in dark environments, which, due to observed strong virucidal behavior in illumination conditions, was attributed to the accidental light exposure while running the assays. Reprinted with permission from ref (95). Copyright 2019 Royal Society of Chemistry. (f) Fabrication process of C60-coated stainless-steel mesh and virus assay setup: (i) electrospraying silica particles on stainless-steel mesh; (ii) hot pressing, (iii) APTES treating silica, (iv) covalent C60 attachment, (v) visible-light-sensitized remote singlet oxygenation and virus inactivation setup. Reprinted with permission from ref (98). Copyright 2020 Elsevier.
Emerging Technologies with Potential to Be Used as Antiviral Coatings
| antimicrobial testing | |||||
|---|---|---|---|---|---|
| material and structure | virus | bacteria | promising features | challenges | ref |
| Micro/nanostructuring | |||||
| nanostructured aluminum | respiratory syncytial virus (RSV) | dual action of antiviral and antibacterial | limited to aluminum surfaces | ( | |
| rhinovirus (RV) | 3- to 4-log reduction in viability counts of RV within 2 h | nanostructures are not controlled during fabrication | |||
| more rapid reduction of RSV than control | |||||
| 92% inactivation of | |||||
| 87% inactivation of | |||||
| mechanically durable, viable option for high-touch surfaces | |||||
| nanostructured anatase–rutile-carbon (NsARC) coating | N/A | photocatalytic activity was shown to present in UV light (4-log reduction in EOP, over 4 h), visible light (3-log reduction), and in the dark (2-log reduction); these results broaden the possible applications to everyday environments | did not investigate durability; currently only grown on stainless steel surfaces | ( | |
| hierarchical micro- and nanostructure based on thin film wrinkling on plastic shrink wraps | N/A | reduces biofouling for bacteria | Requires heating to temperatures of 145C to conform around an object/surface. | ( | |
| flexibility allows them to be used in both medical devices or as medical surfaces | |||||
| hexadecyltrimethoxysilane (HDTMS) modified cotton fabric | N/A | extremely durable, maintained its repellent
properties after washing in solvents and hot
water; simple manufacturing method; inactivation
of | does not investigate why the inhibition zone is created by the hydrophobicity or how the chemical modification would work on other fabrics | ( | |
| Lubricant-infused surfaces | |||||
| fluorosilane-based omniphobic lubricant-infused coating on permeable membrane | N/A | planktonic bacteria | significantly reduced the formation of biofilm growth and formation of a 21 day period | did not investigate potential antibiofouling effects on pathogenic bacteria | ( |
| tethered-liquid perfluorocarbon surface | N/A | reduction of biofilm | ( | ||
| PTFE membrane infused with perfluoropolyether | N/A | PTFE lubricant-infused
substrates showed 99.6% decrease in biofilm
formation in a 7 day incubation under flow, for
| lubricant layer can evaporate over time, resulting in a loss of performance | ( | |
| Liquid/particle-based material | |||||
| GAG mimetic functionalized solid and mesoporous silica nanoparticles (SSN-SO3 and MSN-SO3) | HSV-1 and HSV-2 | N/A | GAG mimetic MSN and SSN act as a viral-binding inhibitor that inhibits HSV 1 and 2 from infecting cells within 1 h | GAG modification is attractive toward viruses, so it should be combined with an antiviral modification | ( |
| poly( | enterovirus, HSV, poliovirus, and HIV coxsackievirus and echovirus human rotavirus, influenza virus, human adenovirus, and Japanese encephalitis virus | N/A | efficient removal of viruses from aqueous solutions based on pyridinium affinity for viruses; 64-fold reduction for HRV, 256-fold reduction for influenza A, 32-fold reduction Ad-37, and 16-fold reduction in JEV after 30 min | toxicity was not discussed and means of use on various surfaces; this method is attractive toward viruses, so it should be combined with an antiviral modification | ( |
| poly( | bacteriophage T4 | N/A | efficient removal of viruses from air based on pyridinium affinity for viruses | a membrane was fabricated, addition of this material to existing membranes was not investigated; this method is attractive toward viruses, so it should be combined with an antiviral modification | ( |
| water-soluble pyridinium-type
polyvinylpyrrolidones with different counteranions
comprising 4-vinylpyridine (4VP) and
| influenza virus | adsorption of the polymer onto the virus
envelope followed by penetration inactivates the
virus at small titers (50 ppm); they also
displayed the ability to inactivate | only showed antiviral effect on enveloped viruses; potential to add on surfaces was not explored | ( | |
| graphene quantum dots (GQDs) suspension | N/A | 90% of both cell species were not viable after 15 min of irradiation with blue light in a 200 μg/mL GQD suspension | performed in solution, not tested against virus titers | ( | |
| silver nanoparticles (Ag-NPs) decorated with GQDs | N/A | minimum inhibitory concentrations of
50 and 25 μg/mL were obtained
for the nanoparticle suspensions against
| performed in solution, not tested against virus titers | ( | |
Figure 6Emerging technologies with potential applications as antiviral coatings. (a) Permeable membrane with fluorosilane based lubricant-infused coating. Schematic of biofouling on membrane with and without the lubricant-infused layer, with SEM of biofouling on untreated and treated membrane, after 21 days of incubation in the insets. Reprinted from ref (125). Copyright 2019 American Chemical Society. (b) Induced nanostructures on aluminum 6063 are shown here via SEM, created by wet etching for (i) 30 min, (ii) 1 h, and (iii) 3 h (scale bars = 2 μm, inset scale bars = 1 μm). (iv) Schematic representations of the etched samples at higher (top) and lower (bottom) magnification. (v) SEM of the 3 h etched surface at higher magnification, revealing the presence of random nanostructures (scale bar = 500 nm). Reprinted from ref (128). Copyright 2020 American Chemical Society. (c) Omniphobic hierarchical wrinkled structure that prevents the adhesion of bacteria and the growth of their biofilms. SEM of the fixed biofilm of P. aeruginosa on (i) planar polystyrene and (ii) hierarchically structured polystyrene surface. The scale bars on larger SEM are 1 μm and the inseted ones are 100 nm. (iii) analysis of bacterial transfer from an intermediate surface to human hands, (iv) bacterial transfer from contaminated surface to planar plastic shrink film and hierarchically structured shrink film. Reprinted from ref (2). Copyright 2020 American Chemical Society. (d) GAG mimetic modified mesoporous silica nanoparticles (i,ii) plaque reduction assay of SSN-SO3 and for HSV1 and HSV2, respectively, (iii) synthesis of GAG mimetic silica nanoparticles, and (iv) schematic of proposed mode of antiviral activity. Reprinted with permission from ref (130). Copyright 2016 Royal Society of Chemistry.